CTLA4 and neoplasm: Recently, the concept of synergistic radiation therapy and immunotherapy was strengthened by showing that tumor cells that were treated with noncurative doses of irradiation induced somatic mutations that were successfully targeted by anti-PD-1/anti-CTLA-4 immunotherapy (Lussier et al. 2021).